For future access to innovative technologies/
novel therapeutic drug targets and collaboration
with early stage startup companies
- Ono Venture Investment Invests in Casma Therapeutics.
(Casma Therapeutics Raises $46.0 M in Series C Funding)
- Ono Venture Investment Invests in Arbor Biotechnologies.
(Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing to Advance Next Generation Precision Editing Therapeutics)
- Ono Venture Investment invests in Immunitas Therapeutics.
(Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases)